ALYREF and neuroblastoma: Mechanistic experiments revealed that MYCN was dependent on ALYREF to drive neuroblastoma cell proliferation and the two proteins acted in a positive interconnected regulatory pathway that was essential for sustaining mutual, oncogenic expression levels.